Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoFAR 3: Oral Desensitization to Egg in Egg-Allergic Children
NCT00461097Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2007
- Primary completion
- Dec 2010
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of egg oral immunotherapy in egg allergy, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2007; status: completed.
02
Drugs
egg oral immunotherapy
03
Conditions
egg allergy
Beyond the preview
Go deeper on NCT00461097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461097.